TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 133 filers reported holding TRANSLATE BIO INC in Q3 2020. The put-call ratio across all filers is 2.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $28,368,000 | +8.0% | 1,030,039 | -35.3% | 0.01% | -14.3% |
| Q1 2021 | $26,261,000 | +45.1% | 1,592,511 | +62.2% | 0.01% | +40.0% |
| Q4 2020 | $18,097,000 | -27.0% | 981,921 | -46.1% | 0.01% | -28.6% |
| Q3 2020 | $24,775,000 | +381.6% | 1,820,327 | +534.2% | 0.01% | +250.0% |
| Q2 2020 | $5,144,000 | +854.4% | 287,015 | +431.2% | 0.00% | – |
| Q1 2020 | $539,000 | +15.7% | 54,031 | -5.7% | 0.00% | – |
| Q4 2019 | $466,000 | +73.2% | 57,321 | +111.2% | 0.00% | – |
| Q3 2019 | $269,000 | -68.4% | 27,136 | -59.7% | 0.00% | – |
| Q2 2019 | $850,000 | +228.2% | 67,332 | +164.7% | 0.00% | – |
| Q1 2019 | $259,000 | +103.9% | 25,435 | +50.7% | 0.00% | – |
| Q4 2018 | $127,000 | -24.0% | 16,874 | +1.0% | 0.00% | – |
| Q3 2018 | $167,000 | -85.9% | 16,701 | -82.1% | 0.00% | – |
| Q2 2018 | $1,183,000 | – | 93,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
| Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
| Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
| DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
| RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
| MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
| Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
| Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
| Birchview Capital, LP | 30,000 | $553,000 | 0.32% |